Zeroscab Lotion 120ml

INTRODUCTION

ZEROSCAB LOTION contains Permethrin which belongs to the group of medicines called Anti-parasitic agents. It is indicated for the treatment of scabies, pediculosis (lice) and crab louse infections.

Scabies is a condition that cause itchy skin caused by a tiny burrowing mite called Sarcoptes scabiei. It can cause intense itching in the area where the mite burrows.

ZEROSCAB LOTION is not recommended for use in patients who are allergic to chrysanthemums (a flower). ZEROSCAB LOTION should be used with caution in patients having lung diseases and eczema (skin disease).

It is not recommended for use in infants below 2 months of age and should be used with caution in children and adolescents below 18 years of age. Consult your doctor before using this medicine.

ZEROSCAB LOTION is not recommended for use in pregnant and breast-feeding women. Consult with your doctor before using.

The most common side effects of using ZEROSCAB LOTION are itching, redness of skin, tingling, prickling, skin burning sensation and dry skin. Ask for your doctor’s advice if any of these worsen or persists for a longer duration.

USES OF ZEROSCAB LOTION

Used to treat:

• scabies
• pediculosis
• crab louse infections

HOW ZEROSCAB LOTION WORKS

ZEROSCAB LOTION helps in treating scabies and head lice by acting on the nerve cells of the disease-causing organism and alters the movements of certain ions (sodium ions) which leads to loss of their function. This causes respiratory failure of the disease-causing organism and hence, their destruction.

DIRECTIONS FOR USE

Always apply ZEROSCAB LOTION as directed by your physician. It is for external use only. The medicine should be applied on all the affected areas. Your doctor will give the right dose depends on your age, body weight and disease condition.

Wash hands before and after the application of ZEROSCAB LOTION. Avoid applying this medicine around your eyes, including eyelids, nose and mouth.

SIDE EFFECTS OF ZEROSCAB LOTION

WARNING & PRECAUTIONS

PREGNANCY

Contraindicated

ZEROSCAB LOTION is not recommended for use during pregnancy. Consult your doctor before using.

BREASTFEEDING

Contraindicated

ZEROSCAB LOTION is not recommended for use in breastfeeding women. Consult your doctor before using.

DRIVING AND USING MACHINES

Use with Caution

ZEROSCAB LOTION is not known to affect your ability to drive or use machines. Consult with your doctor.

ALLERGY

Contraindicated

Do not use ZEROSCAB LOTION if you are allergic to Permethrin or any other pyrethroid such as resmethrin, sumithrin or any of its ingredients

LUNGS

Use with Caution

ZEROSCAB LOTION should be used with caution in patients having lung diseases such as asthma. Consult with your doctor before using.

USE IN PEDIATRICS

Consult your doctor

ZEROSCAB LOTION is not recommended for use in infants below 2 months of age. Your doctor will give the right dose depends on your child’s age, body weight and disease condition. Consult with your doctor before using.

USE IN GERIATRICS

Use with Caution

ZEROSCAB LOTION should be used with caution in elderly patients above 70 years of age. Consult with your doctor before using.

INTERACTIONS

A. Drug-Drug Interactions:

Before using ZEROSCAB LOTION, inform your doctor if you are taking, have taken or might take any other medicine, including prescription, non-prescription, herbal medicine or the following medicine:

• corticosteroids such as clobetasol, betamethasone (use to treat skin allergies)

Overdosage:

If you or anyone else uses too much of ZEROSCAB LOTION, it should be washed off with soap and warm water. In case of accidental ingestion of ZEROSCAB LOTION, consult your doctor immediately or visit the nearby hospital.

SYNOPSIS

MORE INFORMATION

• Keep ZEROSCAB LOTION out of reach of children
• Do not store above 25°C

FAQs ABOUT ZEROSCAB LOTION

Q: What is ZEROSCAB LOTION and why is it prescribed?

A: ZEROSCAB LOTION contains Permethrin which belongs to the group of medicines called Anti-parasitic agents. It is indicated in the treatment of scabies and crab louse infections (head lice).

Q: For how long should I use ZEROSCAB LOTION?

A: Use ZEROSCAB LOTION for the time it has been prescribed by your doctor. Generally, a single application of ZEROSCAB LOTION is sufficient for the treatment. However, it may require a re-application in cases of persistent or reoccurrence of infestation. Ask for your doctor’s advice.

Q: How to use ZEROSCAB LOTION?

A: Always apply ZEROSCAB LOTION as directed by your physician. It is for external use only. The medicine should be applied on all the affected areas. Use this medicine for time it has been prescribed by your doctor even if your symptoms start getting better. Wash hands before and after the application ZEROSCAB LOTION.

Q: Can ZEROSCAB LOTION be used in children?

A: ZEROSCAB LOTION is not recommended for use in infants below 2 months of age and should be used with caution in children and adolescents below 18 years of age. Consult with your doctor before using.

Q: What other precautions should I follow while using ZEROSCAB LOTION?

A: ZEROSCAB LOTION should be applied on all the affected areas. If you have taken a warm bath prior to applying ZEROSCAB LOTION, the skin should be allowed to cool before the medicine is applied.

Q: Is ZEROSCAB LOTION safe for use in pregnant and breast-feeding women?

A: ZEROSCAB LOTION is not recommended for pregnant and breast-feeding women. Consult your doctor before using the medicine.

Q: Can ZEROSCAB LOTION cause prolonged side effects?

A: ZEROSCAB LOTION may cause itching, redness, burning sensation, tingling, prickling or dry skin. Ask for your doctor’s advice if any of these worsen or persists for a longer duration.

REFERENCES

1. KD. Tripathi. Antiseptics, Disinfectants and Ectoparasiticides. Essentials of medical pharmacology. Seventh edition. 2013. Page – 902.

2. D Taplin, T L Meinking, P M Castillero, R Sanchez. Permethrin 1% creme rinse for the treatment of Pediculus humanus var capitis infestation. NIH National Library of Medicine, National center for biotechnology information. Pubmed.gov. September 1986. [Accessed on 20th July 2022] https://pubmed.ncbi.nlm.nih.gov/2430269/

3. Japbani Nanda, Andrew L. Juergens. NIH National Library of Medicine, National center for biotechnology information. Bookshelf. May 2022. [Accessed on 20th July 2022] https://www.ncbi.nlm.nih.gov/books/NBK553150/

4. Sandoz Ltd. Electronic Medicines Compendium (EMC). [Revised in October 2021]. [Accessed on 20th July 2022] https://www.medicines.org.uk/emc/product/6540/smpc#gref

5. GlaxoSmithKline Ltd. Health Products Regulatory Authority (HPRA). [Revised in September 2020] [Accessed on 20th July 2022] https://www.hpra.ie/img/uploaded/swedocuments/a3bdbb9a-3a96-4d62-83d7-6efeb1a8020c.pdf

6. Curatio. Perlice. [Accessed on 20th July 2022] https://curatiohealthcare.com/product/perlice/

7. Medgenix Benelux NV. Health Products Regulatory Authority (HPRA). [Revised in August 2020] [Accessed on 20th July 2022] https://www.hpra.ie/img/uploaded/swedocuments/e6f6b733-128c-400c-9ee9-93e817eddc35.pdf

8. Mayoclinic. [Accessed on 20th July 2022] https://www.mayoclinic.org/diseases-conditions/scabies/symptoms-causes/syc-20377378

AUTHOR DETAILS

Written By Dr. Janet.C, Pharm.D
Last updated on 06 Mar 2023 | 11:31 PM(IST)